Gene Therapy for Adult and Pediatric Patients with Severe Pyruvate Kinase Deficiency: Results from a Global Study of RP-L301

被引：0

作者：

Shah, Ami ^{[1
,2
,3
]}

Sevilla, Julian ^{[4
,5
]}

Lopez Lorenzo, Jose Luis ^{[6
,7
]}

Navarro, Susana ^{[5
,7
,8
]}

Llanos, Lucia ^{[6
,7
]}

de Camino Gaisse, Belgona Perez ^{[6
,7
]}

Sanchez, Sol ^{[6
,7
]}

Zubicaray, Josune ^{[4
]}

Glader, Bert ^{[2
,3
]}

Chien, May ^{[2
,3
]}

Quintana Bustamante, Oscar ^{[5
,7
,8
]}

Gonzalez Vicent, Marta ^{[4
,5
]}

Iriondo, June ^{[4
,5
]}

Rothe, Michael ^{[9
]}

John-Neek, Philipp ^{[9
]}

Bastone, Antonella ^{[9
]}

Schambach, Axel ^{[9
]}

Zeini, Miriam ^{[10
]}

Choi, Grace ^{[10
]}

Nicoletti, Eileen ^{[10
]}

Rao, Gayatri ^{[10
]}

Roncarolo, Maria-Grazia ^{[1
,2
,3
]}

Bueren, Juan A. ^{[5
,7
,8
]}

Schwartz, Jonathan ^{[10
]}

Segovia, Jose-Carlos ^{[5
,7
,8
]}

机构：

[1] Stanford Univ, Ctr Definit & Curat Med, Stanford, CA USA

[2] Stanford Univ, Sch Med, Div Hematol Oncol Stem Cell Transplant Regenerat, Dept Pediat, Stanford, CA USA

[3] Lucile Packard Childrens Hosp, Palo Alto, CA USA

[4] HIUNJ, Fdn Invest Biomed, Hematol & Hemoterapia, Madrid, Spain

[5] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

[6] Hosp Univ Fdn Jimenez Diaz, Inst Invest Sanitaria Fdn Jimenez Diaz IIS FJD, Madrid, Spain

[7] Inst Invest Sanitaria Fdn Jimenez Diaz IIS FJD, Unidad Mixta Terapias Avanzadas, Madrid, Spain

[8] Ctr Invest Energet Medioambientales & Tecnol CIEM, Unidad Innovac Biomed, Madrid, Spain

[9] Hannover Med Sch, Hannover, Germany

[10] Rocket Pharmaceut, Cranbury, NJ USA

来源：

MOLECULAR THERAPY | 2024年 / 32卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：2 / 3

页数：2

共 50 条

[21] Lentiviral-Mediated Gene Therapy for Patients with Fanconi Anemia [Group a]: Updated Results from Global RP-L102 Clinical Trials
Czechowicz, Agnieszka D.
Sevilla, Julian
Booth, Claire
Zubicaray, Josune
Rio, Paula
Navarro, Susana
Cherry, Kritika
O'Toole, Grainne
Xu-Bayford, Jinhua
Ancliff, Philip
Sebastian, Elena
Rothe, Michael
Bastone, Antonella L.
John-Neek, Philipp
Schambach, Axel
Wang, Wei
Choi, Grace
Zeini, Miriam
Nicoletti, Eileen
Eide, Cindy
Wagner, John E.
Rao, Gayatri R.
Thrasher, Adrian J.
Roncarolo, Maria-Grazia
Schwartz, Jonathan
Bueren, Juan A.
Agarwal, Rajni
BLOOD, 2024, 144 : 7463 - 7464
[22] Effects of AG-348, a Pyruvate Kinase Activator, on Anemia and Hemolysis in Patients with Pyruvate Kinase Deficiency: Data from the DRIVE PK Study
Grace, Rachael F.
Rose, Christian
Layton, D. Mark
Yaish, Hassan M.
Barcellini, Wilma
Galacteros, Frederic
Morton, D. Holmes
Ravindranath, Yaddanapudi
Kuo, Kevin H. M.
van Beers, Eduard J.
Kwiatkowski, Janet L.
Silver, Bruce A.
Merica, Elizabeth
Kung, Charles
Cohen, Marvin
Yang, Hua
Hixon, Jeffrey
Kosinski, Penelope A.
Silverman, Lee
Dang, Lenny
Yuan, Zheng
Barbier, Ann J.
Glader, Bertil
BLOOD, 2016, 128 (22)
[23] Lentiviral-Mediated Gene Therapy for Fanconi Anemia [Group A]: Results from Global RP-L102 Clinical Trials
Czechowicz, Agnieszka
Sevilla, Julian
Booth, Claire
Navarro, Susana
Agarwal, Rajni
Zubicaray, Josune
Rio, Paula
Chetty, Kritika
O'Toole, Grainne
Xu-Bayford, Jinhua
Ancliff, Philip
Sebastian, Elena
Choi, Grace
Zeini, Miriam
Nicoletti, Eileen
Eide, Cindy
Wagner, John E.
Rao, Gayatri
Thrasher, Adrian J.
Schwartz, Jonathan
Roncarolo, Maria-Grazia
Bueren, Juan A.
MOLECULAR THERAPY, 2023, 31 (04) : 118 - 118
[24] Gene Therapy for Fanconi Anemia, Complementation Group a: Updated Results from Ongoing Global Clinical Studies of RP-L102
Czechowicz, Agnieszka
Agarwal, Rajni
Sevilla, Julian
Rio, Paula
Navarro, Susana
Beard, Brian C.
Law, Kenneth M.
Choi, Grace
Zeini, Miriam
Nicoletti, Eileen
Wagner, John E.
Booth, Claire
Schwartz, Jonathan D.
Bueren, Juan A.
Roncarolo, Maria Grazia
BLOOD, 2020, 136
[25] Ex Vivo Lentiviral-Mediated Gene Therapy for Patients with Fanconi Anemia [Group A]: Updated Results from Global RP-L102 Clinical Trials
Czechowicz, A.
Booth, C.
Agarwal, R.
Zubicaray, J.
Rio, P.
Navarro, S.
Ancliff, P.
Sebastian, E.
Choi, G.
Zeini, M.
Nicoletti, E.
Wagner, J. E.
Rao, G. R.
Thrasher, A.
Schwartz, J. D.
Bueren, J. A.
Roncarolo, M. G.
Sevilla, J.
MOLECULAR THERAPY, 2022, 30 (04) : 58 - 58
[26] CHARACTERISTICS OF EOSINOPHILIC ESOPHAGITIS IN ADULT AND PEDIATRIC PATIENTS: RESULTS FROM A GLOBAL HEALTHCARE DATABASE
Liu, Benjamin D.
Aly, Mohamed
Song, Gengqing
GASTROENTEROLOGY, 2023, 164 (06) : S355 - S355
[27] EFFECTS OF AG-348, A PYRUVATE KINASE ACTIVATOR, ON ANEMIA AND HEMOLYSIS IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY: EARLY DATA FROM THE DRIVE PK STUDY
Grace, R. F.
Rose, C.
Layton, D. M.
Barcellini, W.
Kwiatkowski, J. L.
Silver, B.
Merica, E.
Kung, C.
Cohen, M.
Yang, H.
Hixon, J.
Kosinski, P. A.
Silverman, L.
Dang, L.
Yuan, Z. J.
Barbier, A. J.
Agresta, S.
Glader, B.
HAEMATOLOGICA, 2016, 101 : 169 - 169
[28] BASELINE CHARACTERISTICS BY AGE OF A GLOBAL COHORT OF PATIENTS DIAGNOSED WITH PYRUVATE KINASE DEFICIENCY - A DESCRIPTIVE ANALYSIS FROM THE PEAK REGISTRY
Bianchi, P.
van Beers, E. J.
Vives Corrons, J. -L.
Glader, B.
Glenthoj, A.
Kanno, H.
Kuo, K. H. M.
Lander, C.
Layton, D. M.
Pospisilova, D.
Viprakasit, V.
Williams, J.
Yan, Y.
Mcgee, B.
Grace, R. F.
HAEMATOLOGICA, 2021, 106 (10) : 107 - 108
[29] Targeted overexpression of human erythroid pyruvate kinase (PK) in transgenic mice: A feasibility study for gene therapy of PK deficiency.
Kanno, H
Fujii, H
Noguchi, T
Koizumi, T
Okabe, M
Yoshimura, Y
Miwa, S
BLOOD, 1996, 88 (10) : 1724 - 1724
[30] Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD
Schwartz, Jonathan D.
Barcellini, Wilma
Grace, Rachel F.
Bianchi, Paola
Zanella, Alberto
Lopez Lorenzo, Jose Luis
Sevilla, Julian
Shah, Ami J.
Glader, Bertil
Nicoletti, Eileen
Navarro Ordonez, Susana
Segovia, Jose Carlos
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (03) : E120 - E125

← 1 2 3 4 5 →